Partnership marks the first introduction of Shield™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines Eligible Manulife customers in Hong Kong ...
FROM THE SCENE. >> JUST UNBELIEVABLE. TJ, THANK YOU SO MUCH. AND WE’RE STILL WORKING TO LEARN WHAT CAUSED A MULTI-CAR CRASH JUST OUTSIDE OF MILWAUKEE’S CENTER STREET LIBRARY THIS AFTERNOON. 12 NEWS ...
HONG KONG, SINGAPORE, and MANILA, Philippines, March 16, 2026 /PRNewswire/ -- Manulife today announced an exclusive partnership with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...
PALO ALTO, Calif. & HONG KONG--(BUSINESS WIRE)--Mar 16, 2026-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield™ multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in ...
10:08, Wed, Mar 11, 2026 Updated: 10:12, Wed, Mar 11, 2026 As Iranian missiles fly in the skies above tourism hotspots in the UAE, the country has been forced to demonstrate the capabilities of its ...
Hosted on MSN
Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia
Guardant Health Inc. (NASDAQ:GH) is one of the most promising stocks under $100 to buy. On March 16, Guardant Health announced the launch of its Shield multi-cancer detection/MCD test in several Asian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results